Table 2.
Bivariate models of associations of baseline mental disorders with subsequent onset of nicotine regular use/dependence
time 1 disorders1 | T2 onset of daily tobacco use among T1 non-daily users 2 | T2 onset of nicotine dependence cases among daily users2 | ||||
---|---|---|---|---|---|---|
OR | (95% CI) | χ2 | OR | (95% CI) | χ2 | |
Mood disorders | ||||||
Dysthymia | 1.5 | (0.4-5.8) | 0.3 | 1.8 | (0.8-3.9) | 2.1 |
Major depression | 1.4 | (0.9-2.3) | 2.6 | 1.4 | (1.0-2.0) | 4.1* |
Bipolar | 1.8 | (0.9-3.7) | 2.7 | 3.9* | 1.7-9.0) | 11.3* |
Any mood disorder | 1.6* | (1.0-2.4) | 4.7* | 1.9* | (1.3-2.5) | 15.3* |
PARP (se) | 0.9 (0.4) | 5.9 (0.5) | ||||
Anxiety disorders | ||||||
Panic disorder | 2.0* | (1.1-3.8) | 4.8* | 0.8 | (0.4-1.6) | 0.4 |
Social phobia | 1.6* | (1.0-2.5) | 4.9* | 1.4 | (1.0-1.9) | 3.8 |
Specific phobia | 1.9* | (1.2-2.9) | 9.1* | 1.3 | (0.9-1.7) | 2.6 |
GAD | 3.0* | (1.2-7.6) | 5.8* | 0.8 | (0.5-1.5) | 0.4 |
PTSD | 1.8 | (0.8-4.1) | 2.1 | 1.7* | (1.1-2.7) | 5.2* |
Agoraphobia | 1.4 | (0.9-2.2) | 1.8 | 2.3* | (1.3-4.0) | 8.9* |
Separation anxiety | 0.8 | (0.4-1.5) | 0.6 | 1.9* | (1.2-3.1) | 6.8* |
Any anxiety disorder | 1.9* | (1.3-2.8) | 11.7* | 1.3 | (0.9-1.7) | 2.7 |
PARP (se) | 13.5 (1.0) | 0.7 (0.5) | ||||
Disruptive Behavior disorders | ||||||
IED | 1.3 | (0.7-2.3) | 0.7 | 1.6* | (1.0-2.4) | 4.7* |
ODD | 1.5 | (0.8-3.0) | 1.5 | 1.7 | (0.9-3.4) | 2.6 |
CD | 1.5 | (0.9-2.5) | 3.0 | 1.6* | (1.1-2.3) | 6.5* |
ADHD | 1.8* | (1.1-2.9) | 6.7* | 1.4 | (0.8-2.3) | 1.6 |
ASPD | 0.7 | (0.1-4.6) | 0.1 | 1.6 | (0.7-3.5) | 1.2 |
Any disruptive behaviour disorder | 1.5 | (1.0-2.2) | 3.8 | 1.5* | (1.1-2.1) | 7.6* |
PARP (se) | 2.0 (0.7) | 3.5 (0.2) | ||||
Substance Use Disorders | ||||||
Alcohol abuse w/wout dep | 2.6* | (1.6-4.4) | 14.7* | 1.7* | (1.2-2.3) | 10.3* |
Alcohol dependence | 3.0* | (1.7-5.5) | 14.1* | 1.8* | (1.3-2.6) | 13.0* |
Illicit drug abuse w/wout dep | 4.2* | (1.8-9.4) | 12.2* | 1.9* | (1.4-2.5) | 19.9* |
Illicit drug dependence | 4.0* | (1.5-10.8) | 7.9* | 1.7* | (1.2-2.4) | 10.7* |
Any substance use disorder | 3.3* | (1.9-5.5) | 21.2* | 1.8* | (1.3-2.4) | 13.7* |
PARP (se) | 15.1 (1.4) | 9.1 (0.5) | ||||
Number of lifetime disorders | ||||||
1 | 1.0 | (0.6-1.8) | 52.6* | 1.1 | (0.6-1.9) | 26.9* |
2 | 2.2* | (1.3-3.7) | -- | 2.0* | (1.2-3.2) | |
3 | 1.7 | (0.9-3.2) | -- | 1.6 | (0.9-2.7) | -- |
4 or more | 4.1* | (2.6-6.5) | -- | 2.4* | (1.5-3.7) | -- |
Any Disorder | 2.0* | (1.4-2.9) | 13.8* | 1.7* | (1.1-2.6) | 6.9* |
Any disorder--PARP (se) | 28.5 (1.3) | 22.2 (0.8) | ||||
N, # positive | (2510) | (255) | (1426) | (543) |
Significant at the .05 level, two-sided test
Mental disorder abbreviations: GAD (generalized anxiety disorder), PTSD (post-traumatic stress disorder) IED (Intermittent explosive disorder), ODD (oppositional defiant disorder), CD (conduct disorder) ADHD (attention deficit hyperactivity disorder) ASPD (antisocial personality disorder).
Controls for age, sex, race, education, marital status, number of children, region, urbanicity, and employment status